Global Blood Glucose Monitoring Devices Market 2025-2029

Blood Glucose Monitoring Devices Market 2025-2029

The blood glucose monitoring devices market is forecasted to grow by USD 10140 mn during 2024-2029, accelerating at a CAGR of 10% during the forecast period. The report on the blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, technological advances in blood glucose monitoring devices, and availability of reimbursement for blood glucose monitoring devices.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's blood glucose monitoring devices market is segmented as below:

By End-user

• Hospitals
• Home care
• Diagnostic centers

By Product

• SMBG
• CGM
• Lancets

By Indication

• Type-2 diabetes population
• Type-1 diabetes population

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the smart watch-based apps as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years. Also, increasing adoption of home healthcare devices and increased adoption of bundled product marketing strategy will lead to sizable demand in the market.

The report on the blood glucose monitoring devices market covers the following areas:

• Blood Glucose Monitoring Devices Market sizing
• Blood Glucose Monitoring Devices Market forecast
• Blood Glucose Monitoring Devices Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, ACON Laboratories Inc., Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Atlas Medical GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., LifeScan IP Holdings LLC, medisana GmbH, Medtronic Plc, Murata Manufacturing Co. Ltd., Nipro Corp., Ok Biotech Co Ltd., Prodigy Diabetes Care LLC, Rossmax International Ltd., TaiDoc Technology Corp., Tandem Diabetes Care Inc., Trivida Health Inc., and Ypsomed Holding AG. Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.